Product
Augmentin
Aliases
Augmentin 500Mg Tablet, Registration number: VN-20169-16
6 clinical trials
12 indications
Indication
Upper Respiratory Tract InfectionsIndication
InfectionsIndication
BacteriaIndication
Otitis MediaIndication
Respiratory TractIndication
Respiratory Tract InfectionsIndication
gallbladder removalIndication
LaparoscopicIndication
Tooth DiseasesIndication
Dental ErosionIndication
ImpotenceIndication
Penile Prosthesis InfectionClinical trial
Application of LiveSpo Navax® in the Treatment Support of Acute Rhinosinusitis and Acute Otitis MediaStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
An Open Label, Single Arm Study, to Evaluate the Pharmacokinetics and Safety of Augmentin Extra Strength (ES)-600 Suspension in Children Presenting With Community Acquired Pneumonia (CAP) and Acute Bacterial Rhinosinusitis (ABRS) in BrazilStatus: Not yet recruiting, Estimated PCD: 2024-01-17
Clinical trial
A Multicenter, Open-label, Non-comparative Phase IV Clinical Study to Evaluate the Safety and Clinical Efficacy of Augmentin Extra Strength (ES)-600 in Children With Acute Otitis Media (AOM) in IndiaStatus: Completed, Estimated PCD: 2022-11-12
Clinical trial
Prophylactic Antibiotic in Non-complicated Low Risk Laparoscopic Cholecystectomy; Is it Worthy? A Prospective Randomized Comparative Study.Status: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
Effects of Pre-operative Antibiotics on the Wound Healing Following Clinical Crown Lengthening SurgeryStatus: Not yet recruiting, Estimated PCD: 2023-10-01
Clinical trial
Collaborative Urological Prosthetics Investigation Directive Research GroupStatus: Active (not recruiting), Estimated PCD: 2024-12-31